Provider of Real-World data that uncovers product & therapeutic gaps to create measurable opportunities with directed purpose
Drug Intelligence leverages actionable data intelligence with 20+ years of direct clinical and industry expertise to a variety of data-driven consulting projects. The basis of our collaborations span across members of the brand team with our own group of medical and commercial experts in primary care and specialty therapeutics.
Market Access & Demonstrating Value
Habib MJ, Merali T, Mills A, Uon V. Canadian Health Care Institution Resource Utilization Resulting From Skeletal-Related Events. Hosp Pract. 2014;42(1)15-22.
Hull RD, Merali T, Mills A, Stevenson AL, Liang J. Venous Thromboembolism in Elderly High-Risk Medical Patients: Time Course of Events and Influence of Risk Factors. Clinical and Applied Thrombosis/Hemostasis. 2013;19(4): 357-362.
Cribb N, Merali T, Donato BMK. Impact of Treatment Strategies on Clinical Outcomes in Chronic Phase Chronic Myeloid Leukemia (CP-CML) Patients in Canada. Abstract and Poster session presented at: 52nd ASH Annual Meeting and Exposition; 2010 Dec 4-7; Orlando, FL.
Hull R, Merali T, Mills A, Liang J, Komari N. Rate and Time Course of Thromboembolism Events in Cancer Patients. Poster session presented at: 6th ICTHIC; 2012 Apr 22; Bergamo, Italy.
Marketing
Hull R, Merali T, Mills A, Liang J. Time Course of Venous Thromboembolism Events and Influence of Risk Factors in High Risk Medical Patients. Abstract presented at: 53rd ASH Annual Meeting and Exposition; 2011 Dec 10-13; San Diego, CA.
Hull R, Bates D, Brocklebank C, Komari N, Merali T. Rate of Late Venous Thromboembolism Events (VTE) in High-Risk Hospital Medical Patients. Abstract presented at: 52nd ASH Annual Meeting and Exposition; 2010 Dec 4-7; Orlando, FL.
Medical
Hull RD, Liang J, Merali T. Effect of Long-Term LMWH on Post-thrombotic Syndrome in Patients With Iliac/Noniliac Venous Thrombosis: A Subanalysis From the Home-LITE Study. Clinical and Applied Thrombosis/Hemostasis. 2013;19(5): 476-481.
Semchuk W, Backstein D, Stewart J, Dessouki E, Kwan M, Lavoie P, Valois M, Mills A, Eikelboom JW. Adherence with Injectable Prophylaxis for Venous Thromboembolism (VTE) Following Total Hip (THR) and Total Knee (TKR) Replacement Surgery: Complete Registry. Abstract presented at: 51st ASH Annual Meeting and Exposition; 2009 Dec 5-8; New Orleans, LA.
Kahn SR, Schulman S, Martineau J, Stewart JA, McLeod A, Strulovich C, Blostein M, Faucher JP, Gamble G, Gordon W, Kagoma P, Miron MJ, Laverdére, Game M, Mills A. Patterns of Management and Adherence to Venous Thromboembolism (VTE) Treatment Guidelines in a National Prospective Cohort Study of VTE Management in the Canadian Outpatient Setting: Recovery Study. Abstract presented at: 52nd ASH Annual Meeting and Exposition; 2010 Dec 4-7; Orlando, FL.
Market Research Insights
Koa H, Merali T, Ali A. Evolving treatment patterns in metastatic melanoma in Canada. Poster session presented at: ISPOR 19th Annual International Meeting; 2014 May 31-Jun 4; Montreal, QC.
Koa H, Merali T, Ali A. Have new therapies changed the face of metastatic castrate-resistant prostate cancer treatment in Canada? Poster session presented at: ISPOR 19th Annual International Meeting; 2014 May 31-Jun 4; Montreal, QC.
